Skip to main content
Premium Trial:

Request an Annual Quote

Aetna to Reimburse for Clinical Data Cardiac Test

NEW YORK (GenomeWeb News) – Clinical Data division PGxHealth today said that Aetna would provide coverage for its Familion family of genetic tests that are used for detecting inherited forms of cardiac channelopathies and cardiomyopathies.
The Newton, Mass.-based firm did not provide financial details of the reimbursement, but it noted that with the in-network coverage for Aetna patients, its Familion tests have positive reimbursement policies from private and public insurers covering an estimated 155 million lives. It also noted that PGxHealth is an approved Medicare provider for its genetic testing services and a Medicaid provider in 37 states and the District of Columbia.
The Familion tests detect genetic mutations that can cause cardiac channelopathies and cardiomyopathies, said Clinical Data. The tests can be used by physicians to help guide treatment and reduce the incidence of fatal cardiac events, the firm said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.